-
Information about Project 8: Myelodysplastic syndromes (MDS)
Objectives
This network aims at integrating the acquired cross disciplinary input from high quality, standardized MDS trials as well as from new molecular knowledge in order to translate them into an improvement in patients' treatment. To perform thi ...
-
Contact Persons in Project 8: Myelodysplastic syndromes (MDS)
The different platforms are grouped into workpackages (WP). Here you can find a list of participants of the WP and WP-leaders as contact persons.
-
Study Groups of Project 8: Myelodysplastic syndromes (MDS)
MDS trial groups willing to cooperate within framework of LeukemiaNet
Budapest MDS group
EBMT MDS subcommittee, Prof. de Witte (http://www.ebmt.org/)
EORTC, Prof. de Witte (http://www.eortc.be/)
German MDS study group, Prof. Aul, Prof. Ganser
GFM gro ...
-
Dates and Meetings
18. ELN/21. KNL Symposium
2022-03-15
- 2022-02-15
7th New Directions in Leukaemia Research (NDLR) meeting
2018-03-25
- 2018-03-28
Brisbane Convention & Exhibition Centre
XXVIII IACRLRD Symposium
2017-10-30
- 2017-11-01
Housto ...
-
List of new treatments potentially interesting for treatment of MDS patients
Deduced from the MDS task force Meeting in Barcelona March 24, 2006 and the subsequent EORTC LG meeting of April 6-8, 2006 in Rome.
-
EU MDS Registry
A prospective, multicenter European Registry for newly diagnosed patients with Myelodysplastic Syndromes of IPSS low and intermediate-1 subtypes.
-
Research activities of Project 8 MDS
-
Recommendations for the management of MDS
The European LeukemiaNet WP8 has promoted a program aiming at developing and continuously updating evidence- and consensus-based guidelines to provide clinical practice recommendations for standardized diagnostic and prognostic procedures and for an appropriate choice of therapeutic interventions in adult patients with primary MDS.
-
Publications
Aggarwal S, van de Loosdrecht AA, Alhan C, Ossenkoppele GJ, Westers TM, Bontkes HJ:
Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy.
Br J Haematol.
2011 Jun;153(5):568-81. ...
-
Minutes and programs of past meetings
Minutes 2014
WP8 meeting at the 11th Annual Symposium of the European LeukemiaNet
(377KB)
February 4 2014, Mannheim
Minutes 2013
WP8 meeting at the 10th Annual Symposium of the European LeukemiaNet
(141KB)
February 5 2013, M ...
-
Links
The Myelodysplastic Syndromes Foundation:
http://www.mds-foundation.org
Work Packages: WP08, Patients, Physicians
National Cancer Institute - Myelodysplastic syndromes:
http://www.nci.nih.gov/cancerinfo/pdq/treatment/myelodysplastic/healthprofessiona ...